HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cristian Garcia-Ruiz Selected Research

IBL-302

1/2020Anti-tumor effects of PIM/PI3K/mTOR triple kinase inhibitor IBL-302 in neuroblastoma.
1/2019Anti-tumor effects of PIM/PI3K/mTOR triple kinase inhibitor IBL-302 in neuroblastoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Cristian Garcia-Ruiz Research Topics

Disease

2Neoplasms (Cancer)
01/2020 - 01/2019
2Neuroblastoma
01/2020 - 01/2019
1Myelodysplastic Syndromes (Myelodysplastic Syndrome)
06/2021

Drug/Important Bio-Agent (IBA)

2IBL-302IBA
01/2020 - 01/2019
2Phosphotransferases (Kinase)IBA
01/2020 - 01/2019
1RNA Splicing FactorsIBA
06/2021
1Cisplatin (Platino)FDA LinkGeneric
01/2019
1N-Myc Proto-Oncogene ProteinIBA
01/2019

Therapy/Procedure

1Drug Therapy (Chemotherapy)
01/2019
1Therapeutics
01/2019